A compound with the SMILES Cc1[nH]nc2nc(SCC(=O)NCC3CCCO3)n(-c3ccc(Br)cc3)c(=N)c12 has a hERG inhibition at a concentration of 1uM of 4.628\%.
A {#drug|compound!} with the {SMILES__description} {SMILES#} has a {herg_central_at_1uM__names__noun} of {herg_central_at_1uM#}{herg_central_at_1uM__units}.
Cc1[nH]nc2nc(SCC(=O)NCC3CCCO3)n(-c3ccc(Br)cc3)c(=N)c12
Cc1[nH]nc2nc(SCC(=O)NCC3CCCO3)n(-c3ccc(Br)cc3)c(=N)c12
[C][C][NH1][N][=C][N][=C][Branch1][S][S][C][C][=Branch1][C][=O][N][C][C][C][C][C][O][Ring1][Branch1][N][Branch1][N][C][=C][C][=C][Branch1][C][Br][C][=C][Ring1][#Branch1][C][=Branch1][C][=N][C][=Ring2][Ring1][N][Ring2][Ring1][=Branch2]
2-[[5-(4-bromophenyl)-4-imino-3-methyl-2H-pyrazolo[3,4-d]pyrimidin-6-yl]sulfanyl]-N-(oxolan-2-ylmethyl)acetamide